Aurora Cannabis (ACBFF) Stock Price, News & Analysis

Company Overview

Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in more than 10 countries worldwide.

Key Stats

• Today's Range: $4.17 to $4.39
• 50-Day Range: $3.88 to $6.62
• 52-Week Range: $2.20 to $12.53
• Volume: 938,049 shs
• Average Volume: 4.22 million shs
• Market Capitalization: $4.08 billion
• P/E Ratio: 35.42
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ACBFF Stock Analysis - Frequently Asked Questions

How have ACBFF shares performed this year?

Aurora Cannabis' stock was trading at $4.25 at the beginning of 2025. Since then, ACBFF stock has increased by 0.0% and is now trading at $4.25.
View the best growth stocks for 2025 here.

Does Aurora Cannabis have any subsidiaries?

Aurora Cannabis subsidiaries include Reliva LLC, Whistler Medical Marijuana Corporation, ICC Labs Inc., Anandia Labs Inc, MedReleaf Corp., CanniMed Therapeutics Inc., Larssen Ltd, and more.

How do I buy shares of Aurora Cannabis?

Shares of ACBFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Private Households
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ACBFF
• CIK: N/A
• Web: auroramj.com
• Phone: 844-928-7672
• Fax: N/A
• Employees: N/A
• Year Founded: 2006

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 35.42
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 960,960,000
• Free Float: N/A
• Market Cap: $4.08 billion
• Optionable: Not Optionable
• Beta: N/A